Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment and communications at the cinema, at home, at work, and on mobile devices. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for TVs, set-top boxes (STBs), personal computers (PCs), gaming consoles, mobile devices, and digital radio; AVC, a digital video codec with high bandwidth efficiency used in media devices; Dolby AC-4, an audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for home theaters, cinemas, device speakers, mobile devices, and headphones.
Read More…
Industry, Sector and Symbol
Industry Patent owners & lessors
Sub-IndustryElectronic Components
SectorConsumer Discretionary
Phone415-558-0200
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$1.24 billion
Profitability
Miscellaneous
Employees2,151
Next Earnings Date1/29/2020 (Estimated)
OptionableOptionable
Dolby Laboratories (NYSE:DLB) Frequently Asked Questions
What is Dolby Laboratories' stock symbol?
Dolby Laboratories trades on the New York Stock Exchange (NYSE) under the ticker symbol "DLB."
How often does Dolby Laboratories pay dividends? What is the dividend yield for Dolby Laboratories?
Dolby Laboratories declared a quarterly dividend on Thursday, August 1st. Investors of record on Monday, August 12th will be given a dividend of $0.19 per share on Tuesday, August 20th. This represents a $0.76 annualized dividend and a yield of 1.10%. The ex-dividend date is Friday, August 9th. View Dolby Laboratories' Dividend History.
How were Dolby Laboratories' earnings last quarter?
Dolby Laboratories, Inc. (NYSE:DLB) issued its quarterly earnings data on Thursday, November, 14th. The electronics maker reported $0.43 earnings per share (EPS) for the quarter, missing the Zacks' consensus estimate of $0.48 by $0.05. The electronics maker had revenue of $298.80 million for the quarter, compared to analysts' expectations of $297.55 million. Dolby Laboratories had a return on equity of 9.34% and a net margin of 20.56%. The firm's quarterly revenue was up 24.2% on a year-over-year basis. During the same period in the prior year, the firm earned $0.44 earnings per share. View Dolby Laboratories' Earnings History.
When is Dolby Laboratories' next earnings date?
What guidance has Dolby Laboratories issued on next quarter's earnings?
Dolby Laboratories updated its FY20 earnings guidance on Thursday, November, 14th. The company provided EPS guidance of $3.40-$3.50 for the period, compared to the Thomson Reuters consensus estimate of $3.54. The company issued revenue guidance of $1.30-$1.35 billion, compared to the consensus revenue estimate of $1.35 billion.
What price target have analysts set for DLB?
5 equities research analysts have issued 1-year target prices for Dolby Laboratories' shares. Their forecasts range from $73.00 to $85.00. On average, they anticipate Dolby Laboratories' share price to reach $79.00 in the next twelve months. This suggests a possible upside of 14.1% from the stock's current price. View Analyst Price Targets for Dolby Laboratories.
What is the consensus analysts' recommendation for Dolby Laboratories?
5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Dolby Laboratories in the last year. There are currently 5 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Dolby Laboratories.
What are Wall Street analysts saying about Dolby Laboratories stock?
Here are some recent quotes from research analysts about Dolby Laboratories stock:
- 1. According to Zacks Investment Research, "Dolby reported healthy fourth-quarter fiscal 2019 results with year-over-year increase in earnings and revenues. Impressive market traction of Dolby Cinema technology is proving to be a major profit churner for the company. It believes that surging demand for premium viewing experience will fuel growth for Dolby Cinema. Dolby’s growth strategy stands on three pillars, which includes advancing the science of sight and sound, providing creative solutions, and delivering superior experiences. However, escalating cost of sales has been a major concern. The company’s Products and Services segment is witnessing declining revenue trends due to soft China market, which is impairing its overall performance. Stiff competition, price-sensitive nature of the entertainment industry and fluctuations of cinema product sales remain other headwinds." (11/18/2019)
- 2. Barrington Research analysts commented, "We continue our OUTPERFORM investment rating on DLB and $85 price target: While the favorable financial impact from the rollout of new technologies continues to evolve, we feel the benefits from some of them are becoming increasingly meaningful. The company’s $0.76 annual dividend provides a yield of 1.2%. The company also is active in repurchasing its shares, with over $400 million in authorization currently remaining. Management has noted that monetization benefits from its cinema sector efforts remain in early stages in terms of financial metrics. However, excitement over the early success of these initiatives has created a more optimistic view of Dolby’s potential to create renewed corporate momentum as management continues to target a return to double-digit growth. Laboratories, Inc." (1/31/2019)
Has Dolby Laboratories been receiving favorable news coverage?
Headlines about DLB stock have trended extremely negative recently, according to InfoTrie Sentiment Analysis. InfoTrie rates the sentiment of media coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Dolby Laboratories earned a coverage optimism score of -4.6 on InfoTrie's scale. They also gave press coverage about the electronics maker a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an effect on the company's share price in the next several days. View News Stories for Dolby Laboratories.
Are investors shorting Dolby Laboratories?
Dolby Laboratories saw a drop in short interest in October. As of October 31st, there was short interest totalling 893,300 shares, a drop of 8.0% from the September 30th total of 970,500 shares. Based on an average daily trading volume, of 312,700 shares, the days-to-cover ratio is currently 2.9 days. Approximately 1.4% of the company's stock are short sold. View Dolby Laboratories' Current Options Chain.
Who are some of Dolby Laboratories' key competitors?
What other stocks do shareholders of Dolby Laboratories own?
Who are Dolby Laboratories' key executives?
Dolby Laboratories' management team includes the folowing people:
- Mr. Kevin J. Yeaman, Pres, CEO & Director (Age 53)
- Mr. Lewis Chew, Principal Financial Officer (Age 56)
- Mr. Andy Sherman, Exec. VP, Gen. Counsel & Corp. Sec. (Age 52)
- Mr. Todd Pendleton, Sr. VP & Chief Marketing Officer (Age 47)
- Mr. Giles Baker, Sr. VP of Consumer Entertainment (Age 43)
Who are Dolby Laboratories' major shareholders?
Dolby Laboratories' stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include TimesSquare Capital Management LLC (1.19%), Marathon Asset Management LLP (0.64%), Sumitomo Mitsui Trust Holdings Inc. (0.48%), Bradley Foster & Sargent Inc. CT (0.25%), Trinity Street Asset Management LLP (0.20%) and First Trust Advisors LP (0.18%). Company insiders that own Dolby Laboratories stock include Bob Borchers, Dagmar Dolby, Ed H Bowman Jr, Giles Baker, Kevin J Yeaman, Lewis Chew, Mark Andrew Sherman, N William Jasper, Jr, Nicholas Donatiello Jr, Peter C Gotcher and Ryan Nicholson. View Institutional Ownership Trends for Dolby Laboratories.
Which institutional investors are selling Dolby Laboratories stock?
DLB stock was sold by a variety of institutional investors in the last quarter, including TimesSquare Capital Management LLC, Chartwell Investment Partners LLC, Marathon Asset Management LLP, Bradley Foster & Sargent Inc. CT, Unigestion Holding SA, Daiwa Securities Group Inc., Janney Montgomery Scott LLC and Great West Life Assurance Co. Can. Company insiders that have sold Dolby Laboratories company stock in the last year include Dagmar Dolby, Ed H Bowman Jr, Giles Baker, Kevin J Yeaman, Lewis Chew, Mark Andrew Sherman, Peter C Gotcher and Ryan Nicholson. View Insider Buying and Selling for Dolby Laboratories.
Which institutional investors are buying Dolby Laboratories stock?
DLB stock was purchased by a variety of institutional investors in the last quarter, including Trinity Street Asset Management LLP, First Trust Advisors LP, State of New Jersey Common Pension Fund D, Sumitomo Mitsui Trust Holdings Inc., Russell Investments Group Ltd., California Public Employees Retirement System, Summit Creek Advisors LLC and Catalyst Capital Advisors LLC. View Insider Buying and Selling for Dolby Laboratories.
How do I buy shares of Dolby Laboratories?
Shares of DLB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.
What is Dolby Laboratories' stock price today?
One share of DLB stock can currently be purchased for approximately $69.25.
How big of a company is Dolby Laboratories?
Dolby Laboratories has a market capitalization of $6.98 billion and generates $1.24 billion in revenue each year. The electronics maker earns $122.24 million in net income (profit) each year or $2.44 on an earnings per share basis. Dolby Laboratories employs 2,151 workers across the globe.View Additional Information About Dolby Laboratories.
What is Dolby Laboratories' official website?
How can I contact Dolby Laboratories?
Dolby Laboratories' mailing address is 1275 MARKET STREET, SAN FRANCISCO CA, 94103. The electronics maker can be reached via phone at 415-558-0200 or via email at [email protected]
MarketBeat Community Rating for Dolby Laboratories (NYSE DLB)
MarketBeat's community ratings are surveys of what our community members think about Dolby Laboratories and other stocks. Vote "Outperform" if you believe DLB will outperform the S&P 500 over the long term. Vote "Underperform" if you believe DLB will underperform the S&P 500 over the long term. You may vote once every thirty days.
